DRIO
DarioHealth Corp. NASDAQ Listed Mar 14, 2016$8.05
Mkt Cap $58.8M
52w Low $5.93
17.9% of range
52w High $17.74
50d MA $8.26
200d MA $10.87
P/E (TTM)
5.9x
EV/EBITDA
-17.2x
P/B
5.3x
Debt/Equity
0.5x
ROE
-61.4%
P/FCF
-21.7x
RSI (14)
—
ATR (14)
—
Beta
1.28
50d MA
$8.26
200d MA
$10.87
Avg Volume
16.8K
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
18 West 18th Street · New York City, NY 10011 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | AMC | -2.44 | -0.80 | +67.2% | 8.24 | -3.2% | -3.0% | -6.1% | +3.5% | -0.8% | +9.7% | — |
| Nov 13, 2025 | AMC | -2.63 | -1.85 | +29.7% | 9.92 | +0.0% | +18.2% | +19.1% | -5.4% | +5.9% | -1.3% | — |
| Aug 12, 2025 | AMC | -2.20 | -2.40 | -9.1% | 8.57 | +5.0% | +5.0% | -3.1% | +2.8% | +0.4% | -2.2% | — |
| May 14, 2025 | AMC | -1.40 | -1.20 | +14.3% | 13.20 | -0.9% | -0.8% | +0.8% | +0.0% | +4.5% | +0.0% | — |
| Mar 10, 2025 | AMC | -3.20 | 0.20 | +106.2% | 13.42 | -0.1% | -7.3% | +1.3% | +2.9% | +2.7% | +3.0% | — |
| Nov 7, 2024 | AMC | -3.60 | -2.60 | +27.8% | 19.40 | +0.0% | -5.2% | -3.3% | -2.8% | -0.2% | -6.6% | — |
| Aug 8, 2024 | AMC | -5.80 | 1.20 | +120.7% | 16.70 | +2.4% | -5.3% | +20.8% | -4.3% | +0.1% | -4.9% | — |
| May 15, 2024 | AMC | -11.80 | -4.00 | +66.1% | 37.00 | -1.6% | +1.6% | +1.1% | -7.4% | +2.8% | -3.9% | — |
| Mar 28, 2024 | AMC | -10.80 | -8.20 | +24.1% | 30.60 | -0.7% | -3.3% | -10.1% | +7.5% | -3.5% | -2.2% | — |
| Nov 2, 2023 | AMC | -10.00 | -9.80 | +2.0% | 20.20 | +5.0% | +32.7% | -3.0% | +0.0% | -7.7% | -10.0% | — |
| Aug 10, 2023 | AMC | -10.40 | -11.60 | -11.5% | 63.00 | -1.0% | +0.3% | +0.3% | -11.0% | -6.0% | -1.9% | — |
| May 11, 2023 | AMC | -9.20 | 9.00 | +197.8% | 77.20 | -0.5% | +3.9% | -5.5% | -0.3% | -1.6% | +1.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 | Stifel | Maintains | Buy → Buy | — | $8.24 | $7.98 | -3.2% | -3.0% | -6.1% | +3.5% | -0.8% | +9.7% |
| Mar 11 | Stifel | Maintains | Buy → Buy | — | $13.42 | $13.40 | -0.1% | -7.3% | +1.3% | +2.9% | +2.7% | +3.0% |
| Apr 1 | Stifel | Maintains | Buy → Buy | — | $30.60 | $30.40 | -0.7% | -3.3% | -10.1% | +7.5% | -3.5% | -2.2% |
| Aug 11 | Alliance Global Partners | Maintains | Buy → Buy | — | $63.00 | $62.40 | -1.0% | +0.3% | +0.3% | -11.0% | -6.0% | -1.9% |
| Jul 25 | Stifel | Maintains | Buy → Buy | — | $73.80 | $74.00 | +0.3% | -6.2% | +4.3% | -2.8% | +6.6% | -0.3% |
| May 12 | Craig-Hallum | Maintains | Buy → Buy | — | $77.20 | $76.80 | -0.5% | +3.9% | -5.5% | -0.3% | -1.6% | +1.3% |
| Nov 16 | Alliance Global Partners | Maintains | Buy → Buy | — | $98.20 | $95.80 | -2.4% | +5.1% | +1.4% | -2.3% | -6.8% | +0.2% |
| Aug 18 | Aegis Capital | Maintains | Buy → Buy | — | $109.80 | $108.60 | -1.1% | -6.9% | -4.1% | +7.6% | -1.1% | -0.2% |
| Aug 16 | Cowen & Co. | Maintains | Outperform → Outperform | — | $134.80 | $133.20 | -1.2% | -13.1% | -6.3% | -6.9% | -4.1% | +7.6% |
| May 16 | Aegis Capital | Maintains | Buy → Buy | — | $117.20 | $116.00 | -1.0% | +11.4% | +10.1% | -10.3% | -1.2% | -2.8% |
| May 16 | Cowen & Co. | Maintains | Outperform → Outperform | — | $117.20 | $116.00 | -1.0% | +11.4% | +10.1% | -10.3% | -1.2% | -2.8% |
| May 13 | Alliance Global Partners | Upgrade | Neutral → Buy | — | $103.60 | $93.00 | -10.2% | +13.1% | +11.4% | +10.1% | -10.3% | -1.2% |
| Jan 26 | Aegis Capital | Maintains | Buy → Buy | — | $172.20 | $176.40 | +2.4% | -4.3% | -3.9% | +5.7% | +4.8% | +0.0% |
| Aug 19 | Aegis Capital | Maintains | Buy → Buy | — | $219.20 | $219.40 | +0.1% | -4.1% | +7.8% | +1.8% | +6.8% | -0.7% |
| Apr 22 | Cowen & Co. | Maintains | Outperform → Outperform | — | $344.40 | $360.40 | +4.6% | +7.4% | +0.3% | +12.9% | -4.7% | +9.1% |
| Mar 23 | Stifel | Maintains | Buy → Buy | — | $484.40 | $493.00 | +1.8% | -6.3% | -12.8% | +4.8% | +0.0% | -7.3% |
| Feb 8 | Aegis Capital | Maintains | Buy → Buy | — | $499.80 | $515.40 | +3.1% | +8.5% | +3.3% | +3.2% | +4.0% | +1.2% |
| Nov 25 | ThinkEquity | Maintains | Buy → Buy | — | $254.60 | $254.60 | +0.0% | +1.4% | -0.2% | -2.6% | -0.9% | -1.4% |
| Nov 25 | Craig-Hallum | Maintains | Buy → Buy | — | $254.60 | $254.60 | +0.0% | +1.4% | -0.2% | -2.6% | -0.9% | -1.4% |
| Nov 25 | Aegis Capital | Maintains | Buy → Buy | — | $254.60 | $254.60 | +0.0% | +1.4% | -0.2% | -2.6% | -0.9% | -1.4% |
| Aug 17 | Aegis Capital | Maintains | Buy → Buy | — | $330.00 | $330.00 | +0.0% | +13.2% | +0.4% | +10.1% | -2.2% | -7.9% |
| Jun 22 | ThinkEquity | Maintains | Buy → Buy | — | $130.60 | $136.00 | +4.1% | +1.7% | -2.1% | -1.8% | -1.3% | -1.6% |
| May 13 | Craig-Hallum | Maintains | Buy → Buy | — | $140.00 | $142.40 | +1.7% | -1.4% | -0.7% | +1.5% | -1.3% | +2.0% |
| Jun 6 | Craig-Hallum | Maintains | Buy → Buy | — | $192.00 | $204.00 | +6.2% | +2.5% | -2.4% | +14.4% | -7.6% | -5.4% |
| Apr 9 | Chardan Capital | Maintains | Buy → Buy | — | $628.00 | $652.00 | +3.8% | +5.7% | +1.2% | -0.6% | +3.0% | +2.3% |
| Aug 29 | Aegis Capital | Maintains | Buy → Buy | — | $800.00 | $808.00 | +1.0% | +6.5% | +2.3% | -3.7% | -6.7% | -4.1% |
| May 9 | Rodman & Renshaw | Maintains | Buy → Buy | — | $2160.00 | $2300.00 | +6.5% | +1.5% | -2.0% | +0.9% | -5.0% | +6.2% |
No insider trades available.
8-K
Unknown — 8-K Filing
I need the complete filing information to provide an accurate analysis. The summary appears incomplete and doesn't clearly specify which company (DRIO, LUCD, or PAVM) filed what action, making it impossible to assess the material impact on shareholders.
Apr 13
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A new executive with deep healthcare operations and Medicare expertise from Fortune 50 Centene and successful acquisition experience joins leadership, potentially signaling strategic shifts in health plan operations or population health initiatives for these companies.
Apr 9
8-K
Unknown — 8-K Filing
DRIO's offering proceeds will primarily fund debt repayment and working capital, reducing financial flexibility for growth investments and potentially signaling cash constraints.
Mar 30
8-K · 5.03
! Medium
DarioHealth Corp. -- 8-K 5.03: Amendment to Articles / Bylaws
DarioHealth Corp. (DRIO) shifted its fiscal year-end, which may affect financial reporting timelines and comparability with prior periods for investors monitoring earnings announcements.
Feb 2
Data updated apr 25, 2026 5:46am
· Source: massive.com